Shu Li

1.6k total citations
71 papers, 841 citations indexed

About

Shu Li is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Shu Li has authored 71 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Shu Li's work include Cardiac Arrest and Resuscitation (7 papers), COVID-19 Clinical Research Studies (5 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Shu Li is often cited by papers focused on Cardiac Arrest and Resuscitation (7 papers), COVID-19 Clinical Research Studies (5 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Shu Li collaborates with scholars based in China, United States and United Kingdom. Shu Li's co-authors include Hongxi Yang, Zhi Cao, Yaogang Wang, Houjuan Xing, Shiwen Xu, Fusheng Xu, Chenglong Han, Xilin Yang, Michael Song and Xiaomin Zheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Shu Li

67 papers receiving 825 citations

Peers

Shu Li
Comparison fields: 5 of 135
  • Health, Toxicology and Mutagenesis 116
  • Immunology 114
  • Molecular Biology 110
  • Physiology 98
  • Pathology and Forensic Medicine 83
Replace Hsin‐Su Yu with:
Hsin‐Su Yu Taiwan
Xuan Wei China
Daryoush Hamidi Alamdari Iran
Hakan Terekeci Türkiye
Guoqi Cai China
Hyun‐Ju Cho South Korea
Eun Kyung Choi South Korea
Jee Young Kim South Korea
Yanbo Liu China
Hsin‐Su Yu Taiwan View profile →
Citations per field, relative to Shu Li
Shu Li · 1×
Citations per year, relative to Shu Li
Shu Li · 1×

Countries citing papers authored by Shu Li

Since Specialization
Citations

This map shows the geographic impact of Shu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Li more than expected).

Fields of papers citing papers by Shu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Li. The network helps show where Shu Li may publish in the future.

Co-authorship network of co-authors of Shu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Li. A scholar is included among the top collaborators of Shu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Li. Shu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 1
3 0
4 7
5 3
6 15
7 1
8 6
9 10
10 7
11 7
12 5
13 9
14 1
15 3
16 12
17
[Prevalence and risk factors of dyslipidemia among adults in Bengbu City in 2014-2015].
1
18
Fumaric acid production using wheat bran hydrolysate in Rhizopus delemar fermentation
1
19 9
20 37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026